Recombinant human keratinocyte growth factor-2 (Newsummit biopharma)
重组人角质细胞生长因子-2（上海新生源医药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human keratinocyte growth factor-2 (Newsummit biopharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWuhan Optics Valley New Medicine Incubation Public Service Platform Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShanghai Sisheng Enterprise Management Consulting Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A